- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00715494
A Pilot Study of Rehabilitation Among Intensive Care Unit (ICU) Survivors: the RETURN Trial (RETURN)
September 10, 2018 updated by: Wes Ely, Vanderbilt University
Returning to Everyday Tasks Utilizing Rehabilitation Networks (RETURN)
Intensive care unit (ICU) hospitalization saves lives but often does so at a high personal cost to ICU survivors who frequently experience significant cognitive impairment and an array of physical and functional disabilities that limit their recovery and quality of life.
While the problems experienced by these patients are likely amenable to rehabilitation, few ICU survivors receive focused rehabilitation following hospital discharge.
The purpose of this study is to initiate and test the feasibility of a complex intervention incorporating a cognitive, physical, and functional rehabilitation program at the time of hospital discharge and implement this 12 week program using in-home visits and tele-technology.
We hypothesize that this interdisciplinary rehabilitation program, initiated at hospital discharge and implemented using in-home visits and tele-technology, will result in improved recovery of neuropsychological and physical performance and overall functional status.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The long-term consequences of critical illness and intensive care unit (ICU) hospitalization in ICU survivors are profound and include cognitive, physical, and functional impairments.
The purpose of this study is to pilot test a 12-week, home-based rehabilitation program targeting both cognitive functioning and physical functioning, to determine the feasibility of such a rehabilitation program, and to determine whether participation in a rehabilitation program will result in improved outcomes among ICU survivors.
The study will rely on a randomized controlled clinical trial design, with patients assigned to either a "usual care" control group vs. the treatment group.
Individuals in the treatment group will receive a protocolized cognitive rehabilitation intervention, as well as individualized physical and functional rehabilitation targeted at abilities such as strength, endurance, balance, and functionality in basic tasks of daily living.
Cognitive, physical, and functional rehabilitation interventions will be delivered in patient homes and will take place on alternating weeks over a 12 week period.
Televideo technology will be employed in the context of these interventions, with experts from Vanderbilt University and Duke University medical centers providing assistance via a video monitor in conjunction with a rehabilitation specialist who will implement interventions in patient homes.
The study has 3 primary outcomes including: (1).
Executive functioning (e.g.
ability to plan, organize, multi-task) over time as measured by the Tower Test, a psychometric tool evaluating executive abilities; (2) Physical Impairment, as measured by the Timed Up and Go (TUG) test; (3) Physical Functioning, as measured by the Step Activity Monitor (SAM).
These three primary outcomes have been selected as areas of primary focus due to the fact that available research points to the presence of significant deficits in these areas among ICU survivors.
Secondary outcomes include activities of daily living (Katz ADL) and instrumental activities of daily living (Pfeffers FAQ), activity specific balance and confidence(ABC Scale), health related quality of life (SF-36), 12-month mortality, and both rehospitalization rates and number of rehospitalization days.
We will measure change in the outcome measures of interest at 3 and 12-month follow up to determine short term efficacy, along with evaluating overall feasibility.
The study duration will include 1 year of protocol development for the complex intervention and 1.5 to 2 years of enrollment.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Enrollment in the BRAIN-ICU study (AG027472-01A1), the presence of cognitive impairment defined via an abnormal Tower Test score (at the time of hospital discharge) and/or physical impairment defined per standard cutpoints for the Timed Up and Go Test (at the time of hospital discharge);
- The ability to walk with or without assistance.
Exclusion Criteria:
- Moderate to severe dementia on ICU admission based on a standardized surrogate assessment (as this would prohibit patients from functioning independently at home);
- The presence of normal cognition and normal physical function at the time of screening (i.e. hospital discharge) which would eliminate the need for rehabilitation;
- Lacking telephone service with an analog telephone line (which would preclude the tele-video component of the RETURN intervention).
- Live greater than 125 miles from Nashville
- Patient is unable to provide informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Group 1 - Control
Patients (Controls) will not receive formal (study-related) rehabilitation interventions and will only receive usual care.
|
|
|
EXPERIMENTAL: Group 2 - Intervention
Participants in the experimental group will receive a focused set of interdisciplinary home-based interventions over a 12 week period.
|
A multicomponent program of cognitive, physical, and functional rehabilitation interventions will be delivered to patients in their home environments over a focused 12 week period with the aid of tele-technology to utilize the expertise of physical therapy, occupational therapy, and neuropsychology.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Tower Test - a psychometric measure of executive functioning
Time Frame: 3 and 12 months post hospital discharge
|
3 and 12 months post hospital discharge
|
|
Timed Up and Go (TUG), a timed test assessing physical strength and gait speed
Time Frame: 3 and 12 months post-hospital discharge
|
3 and 12 months post-hospital discharge
|
|
Step Activity Monitor (SAM), a device that measures total level of participant activity
Time Frame: 3 and 12 months post-hospital discharge
|
3 and 12 months post-hospital discharge
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pfeffers FAQ, a brief measure of higher order (IADL) functioning.
Time Frame: 3 and 12 months post-hospital discharge
|
3 and 12 months post-hospital discharge
|
|
SF-36 global scores
Time Frame: 3 and 12 months post hospital discharge
|
3 and 12 months post hospital discharge
|
|
Katz Activities of Daily Living (ADL) scale
Time Frame: 3 and 12 months post hospital discharge
|
3 and 12 months post hospital discharge
|
|
Activities-specific Balance Confidence Scale (ABC)
Time Frame: 3 and 12 months post hospital discharge
|
3 and 12 months post hospital discharge
|
|
Mortality
Time Frame: Within 12 months of hospital discharge
|
Within 12 months of hospital discharge
|
|
Rehospitalization rate and number of hospital days
Time Frame: Within 12 months of hospital discharge
|
Within 12 months of hospital discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: E Wesley Ely, MD, MPH, Vanderbilt University School of Medicine
- Principal Investigator: Helen Hoenig, MD, MPH, Duke University Medical Center, Durham VA Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2008
Primary Completion (ACTUAL)
September 1, 2009
Study Completion (ACTUAL)
December 1, 2015
Study Registration Dates
First Submitted
July 10, 2008
First Submitted That Met QC Criteria
July 14, 2008
First Posted (ESTIMATE)
July 15, 2008
Study Record Updates
Last Update Posted (ACTUAL)
September 11, 2018
Last Update Submitted That Met QC Criteria
September 10, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 070971
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Weakness
-
St. Luke's-Roosevelt Hospital CenterCompletedFall Risk | Quadriceps Muscle Weakness | Adductor Muscle WeaknessUnited States
-
Lactomason Co., Ltd.RecruitingAge-Related Muscle WeaknessSouth Korea
-
Healthbiome IncCompletedAge-Related Muscle WeaknessSouth Korea
-
Eastern Mediterranean UniversityCompletedPelvic Floor Muscle WeaknessCyprus
-
Association Pro-arteActive, not recruitingWeakness, Muscle | AmyotrophiaFrance
-
University of Central ArkansasCompletedPelvic Floor Muscle WeaknessUnited States
-
Rutgers, The State University of New JerseyRecruitingPhysical Disability | Muscle Atrophy or Weakness | Muscle Loss | Physical Inactivity | Delirium in Old Age | Hospital Acquired Condition | Weakness, MuscleUnited States
-
Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie...CompletedMuscle Weakness | Muscle Weakness Condition | CopdRomania
-
Ludwig Boltzmann Institute of Electrical Stimulation...Medical University of Vienna; European Union; Comenius University; Ministry of...CompletedMuscle Weakness Condition | Therapy EffectAustria, Slovakia
-
University of Texas Southwestern Medical CenterTerminatedMuscle Cramp | Statin Adverse Reaction | Weakness, Muscle | AcheUnited States
Clinical Trials on Cognitive, physical, and functional rehabilitation
-
Vanderbilt UniversityVanderbilt University Medical CenterCompletedBrain Injuries | Dementia | Muscle Disorders | MyopathiesUnited States
-
University of BergenCompleted
-
Centro Universitário Augusto MottaRecruiting
-
Università degli Studi di FerraraRecruiting
-
Sheba Medical CenterCompletedCognitive Rehabilitation | Physical RehabilitationIsrael
-
Virginia Commonwealth UniversityTerminatedMetastatic Brain Tumor | Cerebral MetastasesUnited States
-
Cairo UniversityCompletedDiplegic Cerebral PalsyEgypt
-
VA Office of Research and DevelopmentRecruitingPsychogenic Nonepileptic Seizures (PNES)United States
-
University of Rome Tor VergataRecruiting
-
University Hospital, ToulouseFondation de l'AvenirRecruitingTraumatic Brain InjuryFrance